![Dayle S. Hogg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dayle S. Hogg
Operationeel Directeur bij Gammadelta Therapeutics Ltd.
Profiel
Dayle S.
Hogg is currently a Director at Kesios Therapeutics Ltd.
and the Chief Operating Officer at Gammadelta Therapeutics Ltd.
Previously, Dayle held positions as Principal at Sense Proteomic Ltd., Commercial Manager at Lectus Therapeutics Ltd., and Healthcare Ventures Manager at Touchstone Innovations Investment Management Ltd.
Dayle holds a doctorate degree from the University of Oxford and an undergraduate degree from the University of Leeds.
Actieve functies van Dayle S. Hogg
Bedrijven | Functie | Begin |
---|---|---|
Kesios Therapeutics Ltd.
![]() Kesios Therapeutics Ltd. BiotechnologyHealth Technology Kesios Therapeutics Ltd. provides biotechnology services. It develops novel therapeutics for the treatment of multiple myeloma and other cancers where there are significant unmet medical needs. The company was founded by Menotti Ruvo, Laura Tornatore, and Guido Franzoso on July 13, 2012 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | - |
Gammadelta Therapeutics Ltd.
![]() Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Operationeel Directeur | 01-01-2017 |
Eerdere bekende functies van Dayle S. Hogg
Bedrijven | Functie | Einde |
---|---|---|
Lectus Therapeutics Ltd.
![]() Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lectus Therapeutics Ltd. Developed ion channel modulators and therapeutics. The company was founded in December 2002 and was headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 01-04-2011 |
Touchstone Innovations Investment Management Ltd.
![]() Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Private Equity Investor | - |
Sense Proteomic Ltd.
![]() Sense Proteomic Ltd. Miscellaneous Commercial ServicesCommercial Services Sense Proteomic Ltd. was a functional proteomics company that develops and use protein-related molecular technologies to enhance the productivity of the drug discovery process and the efficacy of the therapies developed from it. It was headquartered in Cambridge, UK. | Corporate Officer/Principal | - |
Opleiding van Dayle S. Hogg
University of Leeds | Undergraduate Degree |
University of Oxford | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Lectus Therapeutics Ltd.
![]() Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lectus Therapeutics Ltd. Developed ion channel modulators and therapeutics. The company was founded in December 2002 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
Sense Proteomic Ltd.
![]() Sense Proteomic Ltd. Miscellaneous Commercial ServicesCommercial Services Sense Proteomic Ltd. was a functional proteomics company that develops and use protein-related molecular technologies to enhance the productivity of the drug discovery process and the efficacy of the therapies developed from it. It was headquartered in Cambridge, UK. | Commercial Services |
Touchstone Innovations Investment Management Ltd.
![]() Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Finance |
Kesios Therapeutics Ltd.
![]() Kesios Therapeutics Ltd. BiotechnologyHealth Technology Kesios Therapeutics Ltd. provides biotechnology services. It develops novel therapeutics for the treatment of multiple myeloma and other cancers where there are significant unmet medical needs. The company was founded by Menotti Ruvo, Laura Tornatore, and Guido Franzoso on July 13, 2012 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Gammadelta Therapeutics Ltd.
![]() Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Health Technology |